Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2020 017 223.8 |
96 | EP file number | EAKZ | 20 72 2936.0 |
86 | WO file number | WAKZ | PCT/US2020/027724 |
97 | EP publication number | EPN | 3856341 |
87 | WO publication number | WPN | 2020210669 |
54 | Designation/title | TI | KRISTALLINE FORMEN VON S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H-PYRAZOL-4-YL)PYRROLO[2,1-F][1,2,4]TRIAZIN-4-YL)PIPERAZINYL)-PYRIMIDIN-5-YL)ETHAN-1-AMIN UND VERFAHREN ZUR HERSTELLUNG DAVON |
51 | IPC main class | ICM (ICMV) | A61P 17/00 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 35/00 (2006.01), A61P 35/02 (2006.01), C07D 487/04 (2006.01), A61K 31/519 (2006.01) |
22 | DE application date | DAT | Apr 10, 2020 |
96 | EP application date | EAT | Apr 10, 2020 |
86 | WO application date | WAT | Apr 10, 2020 |
43 | Date of first publication | OT | Oct 15, 2020 |
| Date of publication of grant | PET | Sep 6, 2023 |
71/73 | Applicant/owner | INH | Blueprint Medicines Corporation, Cambridge, MA, US |
72 | Inventor | IN | WAETZIG, Joshua, D., Cambridge, MA 02139, US; MAR, Brenton, Cambridge, MA 02139, US; HEINRICH, Brian, Cambridge, MA 02139, US; WILKIE, Gordon, Cambridge, MA 02139, US; MACEACHERN, Lauren, Dartmouth, Nova Scotia, B2Y4C3, CA |
74 | Representative | VTR | Mathys & Squire Europe Patentanwälte Partnerschaft mbB, 80333 München, DE |
| Address for service | | Mathys & Squire Europe Patentanwälte Partnerschaft mbB, 80333 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 202062990269 P Mar 16, 2020
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201962833527 P Apr 12, 2019
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201962844575 P May 7, 2019
|
| Due date | FT FG | Apr 30, 2026 Annual fee for the 7th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003856341A1 Searchable text:
EP000003856341A1 Original document:
EP000003856341B1 Searchable text:
EP000003856341B1 Original document:
WO002020210669 Searchable text:
WO002020210669 |
43 | Date of first publication | EVT | Oct 15, 2020 |
| Date of the first transfer into DPMAregister | EREGT | Aug 4, 2021 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 18, 2025 (Show all update days)(Hide all update days)- Apr 18, 2025
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 06.09.2023: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 06.09.2023: deleted
- Mar 15, 2025
- Jul 25, 2024
- Procedures: Opposition procedure, Opposition filed, 05.06.2024: changed
- Jun 20, 2024; Jun 11, 2024; May 15, 2024; May 7, 2024; Nov 29, 2023; Sep 21, 2023; Aug 17, 2023
- Historical data not available for this/these date(s)
- Aug 4, 2021
- Date of the first transfer into DPMAregister
|